FDA approves Pfizer's treatment for rare blood cancer

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

The U.S. Food and Drug Administration said on Wednesday it approved Pfizer Inc's treatment for a rare form of blood cancer in some adults.

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA warns e-cigarette liquid maker against products resembling food for kidsThe U.S. health regulator on Thursday warned a California-based manufacturer and retailer against advertising its e-cigarette liquids with ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

GSK and Pfizer to combine consumer health businessesGlaxoSmithKline Plc and Pfizer Inc said they would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Drugmaker GSK to split after folding in Pfizer consumer unitGlaxoSmithKline Plc and Pfizer Inc said they would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Drugmaker GlaxoSmithKline to split after folding in Pfizer consumer unitGlaxoSmithKline Plc and Pfizer Inc said they would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Drugmaker GSK to split after striking Pfizer consumer health dealGlaxoSmithKline plans to split into two businesses - one for prescription drugs and vaccines, the other for over-the-counter products - after ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer forecasts 2019 revenue, profit below Wall Street targetsPfizer Inc forecast full-year revenue below estimates, after reporting a 2 percent rise in quarterly revenue.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

More blood pressure drugs may have shortages after recalls: FDAAdditional shortages of blood pressure drugs in the United States are possible following recent recalls related to traces of a probable carcinogen ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Novartis' blood disorder drug gets FDA approval for expanded useNovartis AG said on Friday the U.S. Food and Drug Administration expanded the use of its low platelets drug to treat patients with a rare, genetic ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US FDA approves Alexion Pharma's blood disorder drugREUTERS: The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc's blood disorder drug Ultomiris, the pharma regulator's ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

US FDA approves Stemline Therapeutics' rare blood disease treatmentREUTERS: The U.S. Food and Drug Administration on Friday approved Stemline Therapeutics Inc's Elzonris for the treatment of a rare blood disease ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »